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One to three decades may elapse between the onset of
insulin-requiring diabetes mellitus and the development of end-
stage renal failure due to diabetic nephropathy 1—3]. Abnormal-
ities of glomerular function, undetectable by routine laboratory
tests, are present from the onset. Initially, these include a 20 to
40% increase in the glomerular filtration rate (GFR) and a two-
to three-fold elevation of the rate of urinary albumin excretion
above normal [4—71. With the passage of a decade or more,
urinary albumin excretion increases to a level where conven-
tional tests of proteinuria become positive (>100 p.g/min).
Hereafter, a gradual decline in the rate of glomerular ultrafiltra-
tion eventuates [8].
Not surprisingly, the ultrafiltration properties of the glomeru-
lar capillary wall are most impaired after many years of diabetic
nephropathy have elapsed. Retrospective analyses of patients
with diabetic nephropathy commencing dialysis therapy indi-
cate that proteinuria of nephrotic proportions and azotemia are
terminal manifestations, appearing 2 to 4 4years before symp-
tomatic end-stage renal failure necessitates dialysis therapy [9—
101. Accordingly, patients in whom diabetic nephropathy was
accompanied either by the nephrotic syndrome or by azotemia
were selected for a study of glomerular function. The clearance
of graded probe molecules excreted solely by glomerular filtra-
tion was determined. The findings were subjected to previously
described theoretical analyses of glomerular ultrafiltration [11]
and of transcapillary solute exchange through an isoporous
membrane [12] to elucidate those intrinsic properties of the
glomerular capillary wall responsible for reduced water ultrafil-
tration and increased permeability to proteins, respectively.
Methods
Patient population. Glomerular function was studied in 20
consecutive and ambulatory patients referred to the Stanford
University nephrology clinic over a 30-month period (July 1978
to December 1980) because of advanced diabetic nephropathy.
Diabetic nephropathy was diagnosed because of the presence of
heavy proteinuria (>1 g/24 hr) and opthalmoscopic evidence of
diabetic retinopathy in patients with insulin-dependent diabetes
mellitus of long duration (range, 6 to 33 years) [13—15]. It was
graded as advanced because of the presence of azotemia or of
proteinuria of nephrotic proportions (>3.5 g/24 hr) [9, 10].
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Judged by the elevation of serum creatinine concentrations
above 1.4 and 2.0 mg/dl in females and males, respectively, all
but two of the 20 patients were azotemic. Both nonazotemic
patients had nephrotic range proteinuria, as did 15 of the 18
azotemic patients (Table I).
Fifteen healthy volunteers, free of renal disease and normo-
tensive, served as control subjects. Age was not significantly
different between patients with diabetic nephropathy and nor-
mal volunteer control subjects, averaging 48 11 and 49 18
years (mean SD), respectively. The study protocol was
approved by the Stanford University Committee for the Protec-
tion of Human Subjects in Research. Informed consent was
obtained from each patient and volunteer prior to the study.
Protocol. Each patient and volunteer voided spontaneously
after water diuresis had been established with oral water
loading. A constant infusion of inulin and para-aminohippurate
(PAH) was administered to permit the determination of GFR
and effective renal plasma flow (ERPF) from the respective
urinary clearances of each marker as described previously [16].
Dextran-40 (Rheomacrodex, Pharmacia Fine Chemicals, AB,
Uppsala, Sweden) 130 mg/kg was administered by slow (10 mm)
intravenous injection immediately following the inulin/PAH
prime. At the end of a 40- to 60-mm equilibration period, the
bladder was emptied by voiding, after which three carefully
timed 20- to 30-mm urine collections were made. GFR and
ERPF were expressed as the mean value of all three timed urine
collections.
From urine and plasma obtained during the first of these
timed collections, fractional clearances (or sieving coefficients)
of Dextran-40 (01)) were computed, using the equation
= [(U/P)Dl / [(U/P)j (1)
where (U/P)D and (U/P) refer to the urine-to-midpoint plasma
concentration ratios of dextran and inulin, respectively. The
same urine and plasma samples were used for the determination
of the urinary excretion rate of the endogenous proteins,
albumin and immunoglobulin G (lgG), respectively, and for
estimation of these specific proteins as well as of total protein
concentration and colloid osmotic pressure in plasma.
Laboratory methods. For the GFR calculation inulin concen-
tration of urine and plasma was determined using the autoana-
lyzer method of Fjeldbo and Stamey [17]. In this method the
fructose-specific reagent resorcinol, which is uninfluenced by
the presence of dextran, was used. The autoanalyzer method of
Harvey and Brothers was used for the determination of PAH
[181. The concentration of creatinine was determined by a rate-
dependent modification of the Jaffe reaction, employing a
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Table 1. Clinical and laboratory findings
Duration of Serum
Clearance Urinary excretion
diabetes creatinine Inulin PAH Tra Albumin IgG
Age/Sex Years mg/dl ml/min/1.73m2 mm Hg p.g/min
Diabetic nephropathy
Patient no.
1 55/M 20 10.6 3 13 20.7 3219 482
2 54/M 6 4.4 5 26 16.7 2160 470
3 30/F 17 1.7 42 68 17.7 2668 208
4 59/M 14 3.9 11 25 20.0 2839 366
5 66/F 18 2.0 28 162 23.2 1488 102
6 44/F 27 1.4 31 220 21.1 3335 297
7 40/F 21 1.0 64 358 18.0 5952 493
8 57/M 25 2.4 37 299 19.1 2601 41
9 60/M 12 8.3 6 21 25.6 2450 458
10 61/M 25 6.8 7 41 26.2 1733 223
11 50/F 20 4.2 4 10 17.4 2610 350
12 41/F 26 2.9 10 11 12.5 4437 1341
13 46/M 33 4.8 10 45 23.2 3225 361
14 43/F 24 1.1 47 81 17.4 2393 288
15 53/F 8 2.7 15 69 21.3 5192 696
16 31/M 12 6.6 9 39 22.1 3075 409
17 62/M 15 9.7 4 14 20.9 909 203
18 46/F 13 6.0 9 31 20.2 7720 1600
19 32/M 22 3.6 28 151 16.2 6350 950
20 33/M 21 2.6 13 87 10.4 6840 537
Mean 48.2 19.0 4.3 19 89 19.5 3560 494
SD 11.3 6.9 2.8 17 100 3.9 1890 393
SEM 2.5 1.5 0.6 4 22 0.9 423 88
Normal controls (N = 15)
Mean 49.1 — 0.9 100 481 24.2 2.8 —
SD 18.3 — 0.2 37 156 2.7 3.9 —
SEM 4.7 — 0.1 9 42 0.7 1.0 —
Beckman creatinine analyzer [19, 20]. This method minimized
the influence of slow-reacting, noncreatinine plasma chromo-
gens and thus provided an estimate of true creatinine
concentration.
Separation of Dextran-40 and inulin in plasma and urine
samples into narrow fractions (approximately 2 to 4 A) was
accomplished by gel permeation chromatography using a col-
umn (93.5 cm long x 1.6 cm I.D.) packed with Sephacryl S-300
and calibrated with three narrow dextran fractions of known
molecular size provided by the manufacturer (Dextran T10, T40,
and T70, Pharmacia Fine Chemicals, AB, Uppsala, Sweden).
Using 0.3% buffered saline as eluent, 2.6 ml eluted fractions
were collected with an automatic fractionator (Gilson model S-
80). The void volume (V0) was determined with Blue Dextran,
and the fractional volume available to the solute (Kay) was
calculated as
Kay (Ve — V0)/(V — V0) (2)
where Ye is the elution volume of the solute and Vt the total
volume of the gel column [21]. Einstein-Stokes radii (r) for
individual dextran fractions were calculated from Kay [22].
Following gel permeation chromatography of plasma and
urine, eluted fractions were assayed for dextran and inulin
concentrations using a modification of the autoanalyzer an-
throne method of Scott and Melvin [23]. Although inulin and
dextran are both anthrone-positive, cross reactivity was not
encountered because these solutes had differing elution vol-
umes. Dextran standards were used for
dextran-containing fractions (r interval 20
inulin standards were used for the assay of the smaller inulin
molecules which were dispersed over an r range of 11 to 18 A.
Most of the eluted inulin, however, had an r of 13 to 15 A;
therefore, fractions containing molecules in this size range were
used to calculate the (U/P)1 ratio for the subsequent determina-
tion of fractional clearances. It should be noted that (UIP), as
determined by the anthrone method was not significantly differ-
ent from that obtained by the resorcinol method.
Albumin and IgG concentrations in plasma and urine samples
were determined by using a previously described immunochem-
ical technique [24]. Plasma oncotic pressure was determined
with an IL 186 Weil OncometerTa and plasma total protein
concentration with a standard Biuret technique.
Analysis of intrinsic properties of the
glomerular capillary wall
Determination of the glomerular ultrafiltration coefficient
(KJ). Using a mathematical model of glomerular ultrafiltration
described previously [11], an attempt was made to estimate a
range of values for the glomerular membrane ultrafiltration
coefficient (KI). To do this, afferent and efferent arteriolar
plasma protein concentration, Ca and Ce, respectively, preglo-
merular plasma flow rate (approximated by PAH clearance) and
the average transmembrane (glomerular) hydraulic pressure
difference, P, are required. Ce was calculated from the
assaying the early
to 64 A). Separate
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filtration fraction (inulin clearance/PAH clearance, FF) and
from Ca using the equation:
Ce = CaI(1FF) (3)
A value for efferent plasma oncotic pressure (lTe) was derived
then from Ce using the relation [11]:
lTe = aiCe + a2Ce2
[a1 = 1.629 mm Hg/g/dl, a2 = 0.2935 mm Hg/(gIdl)2] (4)
The correlation was verified for use in man by measuring ir
with an oncometer over the range of efferent plasma protein
concentrations encountered in this study (6 <Ce <9 gldl). In
doing so, it was found that equation (4) is accurate to within 2%
over this concentration range.
The transmembrane hydraulic pressure P, represents the
imbalance between the hydraulic pressures prevailing in
glomerular capillaries and in Bowman's space, respectively,
and cannot be determined in man. Therefore, it is assumed that
the range of values likely to prevail in normal subjects is such
that
/P = 1 <(P lTe) lOmmHg (5)
The Kf was determined then for each 1-mm Hg interval over
this range. The lower bound for zP was chosen to approximate
conditions of filtration pressure equilibrium, that is when zP
and the opposing intraglomerular oncotic pressure become
equal at some point in the glomerular capillary network proxi-
mal to its efferent end.
Filtration pressure equilibrium is typical of species such as
the Munich-Wistar rat and squirrel monkey in which glomerular
plasma flow is normally less than 160 nI/mm [25—27]. In the
human kidney containing 2 million glomeruli, effective renal
plasma flow approximates 500 mI/mm. Average glomerular
plasma flow, therefore, is high, averaging 250 nI/mm. At
similarly high glomerular plasma flows in the dog, filtration
pressure equilibrium is not achieved and zP exceeds oncotic
pressure at the efferent end of the glomerular capillary network
by approximately 10 mm Hg [28, 29]. Accordingly, the upper
bound for zP in this study was selected to match the level of
canine filtration pressure disequilibrium.
Evaluation of glomerular permselectivity. The permselective
properties of the glomerular capillary wall were evaluated with
a pore model of transmembrane solute transport. As conceived
by Pappenheimer, Renkin, and Borrero, the glomerular barrier
limiting the passage of macromolecules is assumed to be
perforated by cylindrical pores of identical size (isoporous) [30].
Using this idealization of the glomerular membrane and an
hydrodynamic theory of transport of uncharged macromol-
ecules, the Bowman's space-to-plasma concentration ratio of a
dextran molecule of known size was used to derive values for
pore radius (r0) and the ratio of effective pore area-to-pore
length (s'Il) [12]. Because both dextran and inulin (used as a
reference water marker) are excreted by glomerular filtration
and neither secreted nor reabsorbed by the renal tubule [31], the
foregoing ratio is equal to the fractional urinary dextran clear-
ance (OD). Accordingly, °D for six partially permeant dextran
fractions (r = 30 to 42 A) was used to estimate r0 and s'/l. It has
been shown that Ot is affected not only by intrinsic properties of
the membrane (r0 and s'/l) but also by variations in the diffusive
and convective forces acting on solutes passing through the
membrane [12]. Values for r0 and s'/l were derived, therefore,
for each 1 mm Hg interval over the aforementioned zP range
(36 to 45 mm Hg), using the corresponding values of Kf and
measured values of ERPF, Ca, and Ce. In this manner, varia-
tions in solute and volume flux along the glomerular capillary
were examined.
Interpretation and analysis of membrane parameters. Be-
cause zP has been found to increase in experimental diabetic
nephropathy [321 and in other more severe experimental
glomerular diseases in animals [33—35], values for Kf, r0 and s'/l
were compared in patients with diabetic nephropathy to those
of control subjects at equivalent values for P. It is assumed
that the latter value in diabetic nephropathy is elevated, if
anything, and that the comparison, therefore, is a "worst case"
one.
Statistical methods. All results are expressed as the mean
SEM. Differences in fractional dextran clearances and plasma
oncotic pressures between patients with diabetic nephropathy
and healthy volunteer control subjects were evaluated with
Student's t test for unpaired data.
Results
Gomerular filtration of water and macromolecules. GFR and
ERPF values are listed for individual patients in Table 1. Both
quantities were uniformly depressed below the range observed
in normal subjects. GFR varied between 3 and 64 while ERPF
ranged from 10 to 358 mllmin/l .73 m, respectively.
For the entire diabetic group GFR and ERPF averaged 19 4
and 89 22 ml/minll.73 m2, respectively. As a result the mean
filtration fraction was similar, 0.22 vs. 0.21, in patients with
diabetic nephropathy and control subjects, respectively.
Whereas six control subjects excreted small but measurable
amounts of albumin in their urine (5 to 12 p.g/min), urinary IgG
was undetectable without exception. By contrast, the urinary
excretion of both albumin and IgG was enhanced massively in
all patients with diabetic nephropathy, averaging 3560 423
and 474 88 g/min, respectively. Notwithstanding massive
excretion of albumin (r = 36 A) fractional clearances of dex-
trans with r = 24 to 44 A were depressed relative to those in
control subjects. The opposite was true of the larger dextran
fractions, r = 50 to 64 A, the fractional clearances of which
were elevated above normal. These differences from normal
were significant for several of the smallest (r = 24 to 34 A) and
largest (r = 60 and 64 A) dextrans examined (Fig. 1).
Analysis of glomerular membrane parameters. The serum
protein concentration tended to be depressed in patients with
diabetic nephropathy. Accordingly, ha averaged only 19.5 0.9
mm Hg, a value significantly lower than the 24.2 0.7 mm Hg
prevailing in normal subjects (P < 0.001). The calculated value
for ir in normal subjects was 35 mm Hg. Because there is no
reabsorption along the glomerular capillary network, P must
be equal to or greater than 35 mm Hg. A considerable body of
evidence suggests that in the rat with streptozotocin-induced
diabetes mellitus [32] or with glomerular disease associated
with proteinuria [33—35], P tends to be elevated. It is interest-
ing to note, therefore, that over a 1P range of 36 mm Hg
(approximating filtration pressure equilibrium in normals) to 45
mm Hg (or [P — lTd = 10 mm Hg), values for Kf (Fig. 2) r0
(Fig. 3) and s'/l (Fig. 3) in diabetic nephropathy were uniformly
lower than corresponding values in normal subjects. As shown
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Fig. 1. Fractional dextran clearance profiles in normal controls (0--C)
and patients with advanced diabetic nephropathy (•—I). All results
are expressed as the mean SEM. Symbols: *, P< 0.025; **,P <0.005.
in Figures 2 and 3, elevation of zW in diabetic nephropathy
relative to normal subjects would tend to magnify the depres-
sion of Kf and s'/l while having virtually no effect on r0.
To facilitate the estimation of the magnitude of the differ-
ences observed, a "worst case" comparison of each membrane
parameter was made at equivalent values for P, employing a
hypothetical midrange value of 40 mm Hg (Table 2). As shown
in Table 2, Kf and s'/l in diabetic nephropathy were depressed
to only —13% of normal values. The reduction in r0 in diabetic
nephropathy relative to normal controls, however, was modest,
56.8 vs. 58.0 A.
Many of the input values in our ultrafiltration model were
derived from the rate of renal plasma flow, which was deter-
mined from the clearance of PAH. Because tubular atrophy
may impair the ability of the proximal tubule cell to secrete
PAH in advanced diabetic nephropathy, the effects of a 33%
reduction in PAR extraction upon the computed membrane
parameters were examined when P was 40 mm Hg. As shown
by the values in parentheses in Table 2, the resulting upward
correction of the renal plasma flow rate had a negligible effect
on the calculated values for Kf and s'/l, if anything, tending to
lower these membrane parameters further. A similarly small
effect on r0 increases this quantity from 56.8 to 57.4 A, a value
still slightly smaller than that estimated for control subjects.
Discussion
Several investigators have identified the presence of azote-
mia or the nephrotic syndrome as harbingers of end-stage renal
II Il
36 38 40 42 44 45
P,mm Hg
Fig. 2. Calculated values for glomerular ultrafiltration coefficient (Kf)
in normal subjects (0) and in patients with advanced diabetic nephrop-
athy (•).
failure in patients with diabetic nephropathy [9, 10]. Consistent
with these observations, we demonstrated that GFR is de-
pressed profoundly in diabetic patients with either or both of
these laboratory findings. The GFR may be regarded as the
product of net transmembrane ultrafiltration pressure and the
glomerular ultrafiltration coefficient [11]. It is useful to consider
the relative contribution of each GFR determinant when at-
tempting to elucidate the mechanism of the profound glomeru-
lar hypofiltration observed in these patients.
The net transmembrane ultrafiltration pressure represents the
imbalance between the mean transmembrane hydraulic pres-
sure (P) and mean intraglomerular oncotic pressure (lrGc)
[11]. As stated previously, P cannot be measured directly in
man. It has been shown in the rat, however, that experimental
diabetes mellitus [32] and a reduced nephron population [35] are
associated with alterations in afferent and efferent arteriolar
resistance which result in glomerular capillary hypertension.
This hypertension, in turn, elevates P. Inasmuch as these
experimental models are analogues of advanced human diabetic
nephropathy, the same may be true of this study's experimental
patient population. Our findings also suggested that the oncotic
pressure prevailing along the glomerular capillary in diabetic
nephropathy was reduced. Thus, afferent oncotic pressure,
assumed to be the same as that in systemic plasma, was reduced
by 19% relative to that in normal subjects (19.5 0.9 vs. 24.2
0.7 mm Hg, respectively), while the corresponding reduction of
calculated efferent oncotic pressure was 18% (28.4 vs. 34.8 mm
Hg, respectively). The difference between mean transmem-
brane hydraulic and oncotic pressures, therefore, was likely to
1.0
0.5
0.1 —
0
0.05
.32 —
.28 —
.24 —
.20 -
.16 —
.12 —
.08-
.04 -
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.2 -Z
P
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mm Hg
Fig. 3. Effects of variations in i.P on calculated values for r0 (left) and
s/I (right) in normal subjects (0) and in patients with advanced diabetic
nephropathy (•).
be elevated in patients with advanced diabetic nephropathy. If
this deduction is correct, then it appeared that the reduction of
Kf must be the primary determinant of the severe glomerular
hypofiltration observed.
To calculate Kf in normal subjects, we examined a range of
values for P extending from a lower bound (corresponding to
ire at filtration pressure equilibrium) to an upper bound which
assumes filtration pressure disequilibrium such that (AP — Ire)
= 10 mm Hg. That the foregoing range is reasonable was
suggested by the values derived for Kf using a midrange AP of
40 mm Hg (Table 2). When expressed as an average value for
each of the 2 million glomeruli in normal subjects, the Kf of 0.08
nI sec mm Hg' agreed remarkably with corresponding
values for superficial glomeruli as determined by more direct
methods in all mammalian species examined to date [26—28].
Assuming, for reasons discussed previously, that AP in
advanced diabetic nephropathy was not lower than that in
normal subjects, our theoretical analysis would suggest that
with the former condition Kf is lowered by approximately eight-
fold (Fig, 2, Table 2), a depression of sufficient magnitude to
explain the 80% reduction of GFR in our diabetic population
relative to normal control subjects. The ultrafiltration coeffi-
cient, Kf, is the product of hydraulic permeability (K) and the
surface area available for filtration (S) [11]. Although morpho-
logic studies were not performed during the course of this
study, others have shown that nephrotic range proteinuria and
azotemia in diabetic nephropathy are correlated strongly with
the diffuse and sometimes the nodular form of diabetic glomeru-
losclerosis as well [36, 37]. The greatly expanded mesangial
matrix associated with these pathologic lesions would, by
obliterating many capillary lumina, result in a reduction of
surface area (S) available for filtration. An additional contribu-
tion to a lowered Kf by reduction of hydraulic permeability (K)
cannot be excluded.
The presence of heavy proteinuria in advanced diabetic
nephropathy indicated that the permselective properties of the
glomerular membrane were also deranged. We studied the
transglomerular passage of neutral dextrans to characterize the
glomerulus as a macromolecular sieve. Notwithstanding greatly
enhanced leakage of large plasma proteins into the urine,
transport of neutral dextrans with effective molecular radii (r)
between 24 and 44 A was restricted. By contrast, the transport
of larger dextran molecules (r = 50 to 64 A) was enhanced,
suggesting that the membrane in diabetic nephropathy has a less
sharp "cut off" than normal for large molecules. These findings
can be rationalized by assuming that glomerular pore-size
distribution in advanced diabetic nephropathy is bimodal, with
Normal control
Diabetic
nephropathy
0.160 20.0 58.0
0.020 (0.018) 2.6 (2.3) 56.8 (57.4)
a All calculations assume = 40 mmHg. Values in parentheses
were calculated assuming a PAH extraction ratio of 0.6.
each pore mode representing a separate component of the
glomerular membrane [38, 391. According to this interpretation,
the lower mode represents the major component of the mem-
brane (that is, the larger part of the total membrane area) and
may be regarded as a small-pore ultrafilter which is responsible
for the retention of dextrans of relatively small r. Conversely,
the upper mode represents a minor component of the membrane
(that is, the smaller part of the total membrane area) and may be
regarded as a large-pore ultrafilter through which large dextrans
and plasma proteins are able to penetrate.
At small values of r, the sieving coefficient for the glomerulus
in diabetic nephropathy is predicted to be dominated by the
contribution of the major (or small-pore) part of the membrane.
Accordingly, the fractional clearances of partially permeant
dextrans with radii between 30 and 42 A (O = 0.43 to 0.10) and
a pore model of solute transport were used to characterize the
pore parameters of this major component of the membrane. In
Table 2, the mean pore radius (r0) approximated to 57 A, a value
slightly smaller than the 58 A estimated for the normal human
glomerulus in our control subjects. Determinations of the
effective molecular dimensions of IgG reveal it to have a radius
of 55 A, a value similar in magnitude to the aforementioned
estimate of r0 [40, 41]. As a result IgG should be excluded from
the small-pore component of the glomerular membrane on the
basis of its size alone. If the increased transport of dextrans
with r = 50 to 64 A was indeed through an upper mode of large
pores, it seems likely that the increased leakage of IgG from
plasma into the urine was also effected by this route.
Albumin (r = 36 A) is smaller than IgG and the massive
enhancement in its filtration and urinary excretion in diabetic
nephropathy could, in theory, be via both pore modes. There is
now substantial evidence to indicate that notwithstanding re-
duction of pore size and/or density, proteinuria in a variety of
glomerular diseases maybe associated with the depletion of the
fixed negative charges in the glomerular capillary wall [42—44].
Enhanced transglomerular transport of the highly anionic albu-
min molecule is believed to result from loss of electrostatic
retardation [42—44]. Cytochemical and compositional studies of
glomeruli from patients with diabetic nephropathy reveal
glomerular polyanion to be depleted [45, 46]. Therefore, it is
tempting to attribute albuminuria in diabetic nephropathy to a
combined defect of the size and charge selective properties of
the glomerular capillary wall, while increased urinary IgG
excretion appears to reflect an impaired size-selective barrier
alone.
Our theoretical analysis of solute transport through pores
suggests that restricted transport of dextrans of relatively small
r was primarily a result of a profound reduction in the ratio of
60
58
56
54
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_
•Diabetes mellitus
I I I I I I I
36 38 40 42 4445 36 38 40 42 4445
30
25
20
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Table 2. Membrane parameters
Kf s/I r0
ml sec I mmHgI.73m 2 clii x /06 A
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effective pore area-to-pore length (s'II). The scierosing process
characterizing the glomerulus in advanced diabetic nephrop-
athy suggests that any reduction of the s' term results most
likely from obliteration of capillary lumina [361. Simultaneous-
ly, an increase in the thickness of the glomerular basement-
membrane, widely regarded as an important part of the limiting
barrier to macromolecule filtration [471, may lead to an increase
in the 1 term. Morphometric studies, however, reveal that, on
the average, the width of the thickened basement membrane in
advanced diabetic nephropathy is unlikely to exceed normal by
more than two- to three-fold [48, 491. Given that, s'/l in patients
with diabetic nephropathy is eight-fold smaller than that in
normal subjects; this finding then may be interpreted to indicate
a substantial reduction in the s' term and hence in pore density.
As stated previously, the foregoing analysis was predicated
upon the assumption that i.P varies between 36 and 45 mm Hg
in both the control and experimental populations. In the case of
normal subjects, the bottom of this range is set by the calculated
value of 'iTe. In patients with diabetic nephropathy, however, lie
averaged only 28.4 mm Hg. It is theoretically possible, there-
fore, that P in these patients was depressed below the lower
bound of our assigned range. Even in these circumstances our
analysis indicates that Kf and s'/l would remain substantially
depressed below corresponding values in the "normal range"
unless filtration pressure equilibrium obtained, that is, LP = ITe
= 28.4 mm Hg. The following two points suggest that this
condition is unlikely to obtain in diabetic nephropathy: (1)
Although glomerular plasma flow is sufficiently low for filtra-
tion pressure equilibrium to be achieved in the normal Munich-
Wistar rat, the induction of a variety of primary glomerular
diseases in that species has been associated invariably with
filtration pressure disequilibrium [33, 34, 43]. That this disequi-
librium is also true of glomerular disease in man is suggested by
the observation that even large increases in plasma flow in-
duced by infusing albumin into nephrotic subjects failed to
effect an increase in GFR [50]. Plasma flow independence of
GFR strongly suggests filtration pressure disequilibrium, thatP > lie [25]j2) Our mathematical model of ultrafiltration
revealed that if P is 28.4 mm Hg in patients with advanced
diabetic nephropathy, then Kf =0.13 ml sec mm Hg 1.73
m2. If this finding is construed to indicate that the intrinsic
properties of the glomerular membrane in diabetic nephropathy
are normal, then the findings for transglomerular dextran trans-
port should be consistent with normality as defined by healthy
control subjects. According to transport theory, a reduction in
P from normal (>35 mm Hg) to 28.4 mm Hg without a
concomitant reduction in Kf will always result in enhanced
transport of neutral macromolecules [121 and not in reduced
transport, as was observed for dextrans in the r range 24 to 44 A
(Fig. 1).
In conclusion, we propose that our findings are explained
best by a profound reduction below normal of Kf and s'/l and
point to a progressive loss of glomerular filtering surface area as
the major cause of the irrevocable renal failure that character-
izes advanced diabetic nephropathy. Judged by a selective
enhancement of transglomerular transport of large neutral dex-
tran molecules (r = 50 to 64 A), the glomerular membrane in
advanced diabetic nephropathy also appeared to develop isolat-
ed membrane defects. It is suggested that these defects behaved
as an upper mode of large pores, and account for, at least in
part, the appearance of massive and nonselective proteinuria as
a near-terminal event during the evolution of diabetic
nephropathy.
Summary. Intrinsic membrane properties of the glomerular
capillary wall were evaluated in 20 diabetic patients, who had
heavy proteinuria and reduced GFR, and in 15 healthy control
subjects. The glomerular sieving coefficients were determined
for narrow dextran fractions with molecular radii between 20
and 64 A. GFR determinants were directly measured or indirect-
ly estimated. These quantities were then subjected to a theoreti-
cal analysis based upon (1) a mathematical model of glomerular
ultrafiltration and (2) a pore model of transmembrane solute
transport. The results indicated that in patients with diabetic
nephropathy the glomerular ultrafiltration coefficient (0.02 vs.
0.16 ml sec' mm Hg' l.73m2), effective pore area-to-
pore length (2.6 x 106 vs. 20.0 x 106 cm), and mean pore radius
(56.8 vs. 58.0 A) are all reduced relative to normal control
subjects. It is suggested that (1) hypofiltration in advanced
diabetic nephropathy results, in part, from reduction of the
surface area available for filtration, while (2) proteinuria is a
consequence of either loss of electrostatic barrier function, of
isolated focal disruptions within the glomerular filtration barri-
er, or a combination thereof.
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